LENSAR, Inc. (LNSR) Fair Value 2026

LNSR · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.1 /10

32 fundamental signals · 2 models active

Value Trap Risk

SAFE (24/100)

Quick Summary — As of 2026-08-27, LENSAR, Inc. (LNSR) trades at $8.46, versus a $9.47 median fair value across its 2 active models — 12.0% above the current price. QOC: 7.1/10. Value Trap Risk: 24/100 (SAFE). 2/13 models active.

Key Facts

Ticker
LNSR
Price
$8.46
Quality Score
7.1/10
Value Trap Risk
24/100
Models Active
2/13
Last Updated
Strength: ML-RIV suggests +31.5% upside with 55% confidence
Risk: Limited model coverage (2/13) may reduce confidence

Is LENSAR, Inc. (LNSR) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, LENSAR, Inc. (LNSR) appears undervalued as of : the median of 2 independent fair value estimates is $9.47, 12.0% above the current price of $8.46. Estimates range from $7.83 to $11.12. LNSR scores 7.1/10 on fundamental quality and 24/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. LNSR’s +12.0% gap is narrower than that market norm, and the Medical Devices sector median is -43.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy LENSAR, Inc. Stock in 2026? →

What Fair Value Does Each Model Give LNSR?

2 Intrinsic Value Models vs. Current Price ($8.46)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $11.12 +31.5%
Relative · Low Conviction
 $7.83 -7.5%

All Models Active

All 2 models are displayed above.

What Is LENSAR, Inc. (LNSR) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, LENSAR, Inc.'s intrinsic value is estimated at $9.47, presenting a divided outlook at the current price of $8.46. With a median implied return of +12.0% across a split 1–1 (bull–bear) consensus, the model spread of +39.0% underscores analytical uncertainty. Notably, ML-RIV sees the most upside at +31.5% (fair value: $11.12), while Regime Cross is the most conservative at -7.5% ($7.83). The spread between these extremes — +39.0% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About LNSR?

2 of 13 models are currently active for LNSR. Of these, 1 model suggests upside while 1 model suggests overvaluation. Taken together, their median fair value for LNSR is $9.47 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does LNSR Rank in Medical Devices?

Among 157 Medical Devices stocks, LNSR ranks #46 by Quality of Company score. CirclFi's QOC score of 7.1/10 evaluates 32 fundamental signals. A score of 7.1 indicates above-average quality.

See all Most Undervalued Medical Devices Stocks →

Within the Medical Devices space, LENSAR, Inc. competes in an environment where R&D productivity ratio often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is LNSR a Value Trap?

CirclFi's Value Trap algorithm assigns LNSR a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for LENSAR, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, LENSAR, Inc. is rated at 7.1/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.

The gap between the most bullish and bearish model spans +39.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every LNSR valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across LNSR's 2 active models, average confidence is 37%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy LENSAR, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

NVCRNovoCure LimitedQOC 7.1IRTCiRhythm Holdings, Inc.QOC 7.1KIDSOrthoPediatrics Corp.QOC 7.1MASS908 Devices Inc.QOC 7.1PHGKoninklijke Philips N.V.QOC 7.1ESTAEstablishment Labs Holdings Inc.QOC 7.0BBNXBeta Bionics, Inc.QOC 6.1TNONTenon Medical, Inc.QOC 5.0TMDXTransMedics Group, Inc.QOC 9.2IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: NVCR · IRTC · KIDS · MASS · PHG · ESTA · BBNX · TNON · TMDX · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to LNSR?

7 companies across all industries closest to LNSR’s Quality of Company score of 7.1/10.

RTORentokil Initial plcQOC 7.1MSSMaison Solutions Inc.QOC 7.1ZETAZeta Global Holdings Corp.QOC 7.1AINAlbany International Corp.QOC 7.1ICGIntchains Group LimitedQOC 7.1INRInfinity Natural Resources, Inc.QOC 7.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: RTO · MSS · ZETA · AIN · ICG · INR · NVDA

Where Does LNSR Sit in CirclFi's Medical Devices Rankings?

LNSR is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About LENSAR, Inc.’s Valuation?

What is LENSAR, Inc.'s intrinsic value in 2026?

CirclFi puts LENSAR, Inc. (LNSR)'s intrinsic value at $9.47 — the median of 2 independent model estimates as of 2026-08-27, ranging from $7.83 to $11.12. The Quality of Company score is 7.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is LNSR overvalued or undervalued right now?

At $8.46, 1 of 2 active models suggest LNSR may be undervalued, while 1 indicate potential overvaluation. The median of all 2 fair value estimates is $9.47, 12.0% above the current price of $8.46 — a consensus view that LNSR is undervalued. The assessment depends on which methodology best fits LENSAR, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 7.1 mean for LNSR?

LENSAR, Inc.'s QOC of 7.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on LNSR?

CirclFi analyzes LNSR with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is LNSR a value trap in 2026?

LENSAR, Inc.'s Value Trap score is 24/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, LENSAR, Inc. (LNSR) has a median fair value of $9.47 — 12.0% above the current price of $8.46 — as of 2026-08-27.” Source: circlfi.com/stock/LNSR/ · Methodology
Primary sources for this LNSR valuation
  • Financial statements: LENSAR, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001320350) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for LNSR as of ; valuations recomputed .